The Utility of Salivary 11-Dehydrodexamethasone as a Marker of Dexamethasone Absorption
Listen to this summary
The authors investigate whether salivary 11-dehydrodexamethasone (11-DHD) can serve as a reliable marker for dexamethasone (DXM) absorption in patients undergoing the overnight dexamethasone suppression test (ONDST). Their findings reveal a strong positive correlation between serum DXM levels and salivary 11-DHD, suggesting that measuring 11-DHD could enhance the diagnostic process by allowing for convenient at-home sample collection. This novel approach may improve patient pathways in the assessment of hypercortisolism.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The Journal of clinical endocrinology and metabolism
View all →Jun 11, 2026 · The Journal of clinical endocrinology and metabolism
Approach to the Patient: Cases of Hormonal Management in Older Transgender and Gender Diverse Adults
Jun 11, 2026 · The Journal of clinical endocrinology and metabolism
Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis
More in Pediatrics
View all →Aug 7, 2026 · European heart journal
Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies
Aug 7, 2026 · Critical care medicine
Geographic Access to Care and Mortality in Cardiogenic Shock: A Nationwide Cohort Analysis
Aug 7, 2026 · Pediatric nephrology (Berlin, Germany)
Anti-rituximab antibodies: implications for clinical outcomes and safety in pediatric idiopathic nephrotic syndrome
Aug 7, 2026 · Critical care medicine
Rethinking Muscle Wasting in Critical Illness: A Systematic Review and Meta-Analysis of Myofiber Size and Protein Turnover
Aug 7, 2026 · Critical care medicine
Telemedicine Critical Care Billing For Hospitalized Medicare Fee-For-Service Beneficiaries, 2018-2024
Aug 7, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


